Finance

Lists
300601:SHE
Shenzhen Kangtai Biological Prods Co Ltd
CN¥12.07
-1.15%
(-0.14) 1D
Oct 30, 3:04:04 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300601...
Open
CN¥12.09
High
CN¥12.61
Low
CN¥11.99
Mkt. cap
13.48B
Avg. vol.
17.09M
Volume
15.54M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 11, 2026
P/E ratio
116.79
52-wk high
CN¥17.76
52-wk low
CN¥10.70
EPS
CN¥0.10
Shares outstanding
1.12B
No. of employees
2K
Open
CN¥12.09
High
CN¥12.61
Low
CN¥11.99
Mkt. cap
13.48B
Avg. vol.
17.09M
Volume
15.54M
Dividend
0.37%
Quarterly dividend
CN¥0.01
Ex-dividend date
Jun 11, 2026
P/E ratio
116.79
52-wk high
CN¥17.76
52-wk low
CN¥10.70
EPS
CN¥0.10
Shares outstanding
1.12B
No. of employees
2K
News stories
From web sources and news partners
Profile
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products. Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
About Shenzhen Kangtai Biological Prods Co Ltd
CEO-
Employees1.96K
FoundedSep 8, 1992
Headquarters-
SectorBiotechnology
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
609.64M
631.11M
641.89M
567.83M
Cost of goods sold
267.74M
182.40M
218.78M
133.97M
Cost of revenue
267.74M
182.40M
218.78M
133.97M
Research and development expenses
123.35M
84.28M
90.88M
79.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
283.35M
302.79M
284.34M
265.24M
Operating expense
428.59M
406.24M
402.08M
349.76M
Total operating expenses
696.33M
588.65M
620.87M
483.72M
Operating income
-86.69M
42.47M
21.03M
84.11M
Other non operating income
308.38K
-2.04M
1.69M
-4.88M
EBT including unusual items
45.26M
39.95M
1.37M
35.59M
EBT excluding unusual items
-104.26M
19.66M
-1.09M
59.97M
Income tax expense
24.17M
6.35M
-12.75M
-8.65M
Effective tax rate
53.40%
15.89%
-932.00%
-24.29%
Other operating expenses
14.05M
6.96M
12.14M
2.93M
Net income
21.17M
33.34M
17.05M
44.97M
Net profit margin
3.47%
5.28%
2.66%
7.92%
Earnings per share
-
-
-
-
Interest and investment income
13.75M
8.72M
9.41M
8.50M
Interest expense
-30.16M
-29.50M
-29.76M
-31.22M
Net interest expenses
-16.42M
-20.77M
-20.35M
-22.72M
Depreciation and amortization charges
-
-
-
-
EBITDA
11.74M
140.90M
126.83M
182.54M
Gain or loss from assets sale
934.47K
-
-5.69K
5.69K
Upcoming events
AI content may include mistakes. Learn more
Google apps